PRESS RELEASE

Munich, 1 October 2024

The CERTANIA Group is a strategic investor in Testing, Inspection, Certification and Research (TIC) with the goal of building a network of leading companies that contribute to health and sustainability in operations and their ecosystems. This is based on companies that combine in-depth expertise with outstanding customer service to create a winning formula. In the CERTANIA Group, their competencies are brought together to create holistic solutions and serve customers along the entire value chain. CERTANIA Holding has a long-term investment plan around successful partnerships with management teams, with the goal of jointly building a leading TIC group. The partners of the CERTANIA Group maintain a strong independence and preserve their entrepreneurial drive. Through their partnership within the CERTANIA Group, they will have the opportunity to combine and jointly develop their expertise from different TIC sectors to meet the ever-growing consumer need for transparency and verification in health and sustainability – while maintaining their identity.

Founded in 1976 and headquartered in Bad Kissingen, Germany, Institut Dr. Nuss has established itself as a premier provider of environmental analysis. The institute employs the latest technology in their laboratories to analyse a wide variety of matrices for environmental and health-related contaminants and ingredients. Along with a diversified clientele, including medium-sized European companies, public institutions, and private individuals, the institute ensures operational stability and long-term growth.

Both sides have agreed not to disclose details of the transactions.

ADVISORS CERTANIA-Group:

honert (Munich): Patrick Spalek (lead), Andrea Hötzel, Dominik Kastner (all corporate law, M&A)